Intensification of Insulin Treatment With Insulin Degludec/Aspart in Type 2 Diabetic Patients: A 2-Year Real-World Experience

Intensification of Insulin Treatment With Insulin Degludec/Aspart in Type 2 Diabetic Patients: A 2-Year Real-World Experience

AimTo evaluate the effects of insulin degludec/insulin aspart (IDegAsp) coformulation as an intensification of insulin treatment for glycemic control in patients with type 2 diabetes (T2D) in a long term real-world clinical setting.Materials and MethodsThis retrospective non-interventional study, in...

Full description

Bibliographic Details
Main Authors: Hatice Oner, Hatice Gizem Gunhan, Dilek Gogas Yavuz
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-07-01
Series:Frontiers in Clinical Diabetes and Healthcare
Subjects:
Keywords: IDegAsp1
insulin2
degludec3
real world4
type 2 diabetes5
intensification6
Online Access:https://www.frontiersin.org/articles/10.3389/fcdhc.2022.783277/full

Internet

https://www.frontiersin.org/articles/10.3389/fcdhc.2022.783277/full

Similar Items